SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1687)10/11/2006 1:04:48 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
XTLB is also going up for 3rd day on a roll with
no news that I am aware.<g>

They said back in May that they were starting a P1
on XTL-125 for hepatitis C and in July Cubist said
at their annual meeting that they weren't going to
make any further investment in the Herpex-B program.
(XTLB had licensed to Cubist the Herpex-B in 2004)

The stock totay is testing its Aug.11 H at 3.45
The next resistance will be the Jul.31 H at 3.74 which
of course, looks more important.<g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (1687)2/13/2007 2:58:03 PM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
SQNM is moving today after it announced that it has acquired rights to non-invasive prenatal diagnostic tests using fetal nucleic acids obtained from maternal serum or plasma.

The rights were obtained from the Chinese University of Hong Kong and cover USA, Europe, Australia, Canada and Japan.

The stock traded above the resistance at 4.75 (4.79 at 1:24PM), but is now at 4.74 >g>

bigcharts.marketwatch.com

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News